The prognostic value of high-sensitive C-reactive protein and cardiac troponin T in young and middle-aged patients with chest pain without ECG changes

European Journal of Internal Medicine

Volumn 14, Issue 5, 2003, Pages 310-314

  Blum, Arnon ^a   Safori, Gassan ^a   Hous, Nir ^a   Lupovitch, Sacha ^a  

^a Poriya Hospital   (Israel)

Author keywords

Cardiac troponin T; High sensitive C reactive protein

Indexed keywords

BIOCHEMICAL MARKER; C REACTIVE PROTEIN; CREATINE KINASE MB; TROPONIN T;

ADULT; ANGINA PECTORIS; ARTICLE; BLOOD; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DISEASE COURSE; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HUMAN; LABORATORY TEST; MALE; PROGNOSIS; PROTEIN BLOOD LEVEL; SERUM; THORAX PAIN;

EID: 0041886713     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0953-6205(03)00099-2     Document Type: Article

References (53)

1. Braunwald E., Jones R.H., Mark D.B., et al. Diagnosing and managing unstable angina. Circulation. 90:1994;613-622.
2. Braunwald E. Unstable angina: an etiologic approach to management. Circulation. 98:1998;2219-2222.
3. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study. Lancet. 349:1997;1429-1435.
4. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. New Engl J Med. 338:1998;1498-1505.
5. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. New Engl J Med. 338:1998;1488-1497.
6. Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. Circulation. 96:1997;1445-1453.
7. Ridker P.M., Hennekens C.H., Buring J.E., et al. C reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. New Engl J Med. 342:2000;836-843.
8. Kuller LH, Tracy RP, Shaten J. et al. for the MRFIT Research Group. Relationship of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Am J Epidemiol 1996;144:537-47.
9. Ridker P.M., Cushman M., Stampfer M.J., et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. New Engl J Med. 336:1997;973-979.
10. Tracy R.P., Lemaitre R.N., Psaty B.M., et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol. 17:1997;1121-1127.
11. Ridker P.M., Buring J.E., Shih J., et al. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation. 98:1998;731-733.
12. Ridker P.M., Cushman M., Stampfer M.J., et al. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation. 97:1998;425-428.
13. Koenig W., Sund M., Froelich M., et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (MONIitoring trends and determinants in Cardiovascular disease) Augsberg Cohort Study, 1984 to 1992. Circulation. 99:1999;237-242.
14. Roivainen M., Viik-Kajander M., Palosuo T., et al. Infections, inflammation, and the risk of coronary heart disease. Circulation. 101:2000;252-257.
15. Harris T.B., Ferrucci L., Tracy R.P., et al. Association of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med. 106:1999;506-512.
16. Danesh J., Whincup P., Walker M., et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. Br Med J. 321:2000;199-204.
17. Mendall M.A., Strachan D.P., Butland B.K., et al. C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men. Eur Heart J. 21:2000;1584-1590.
18. Liuzzo G., Biasucci L.M., Gallimore J.R., et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. New Engl J Med. 331:1994;417-424.
19. Morrow D., Rifai N., Antman E., et al. C-reactive protein is a potent predictor of mortality independently and in combination with troponin T in acute coronary syndromes. J Am Coll Cardiol. 31:1998;1460-1465.
20. Biasucci L.M., Liuzzo G., Grillo R.L., et al. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation. 99:1999;855-860.
21. Lindahl B, Toss H, Siegbahn A et al. for the FRISC Study Group. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. New Engl J Med 2000;343:1139-47.
22. Haverkate F., Thompson S.G., Pyke S.D.M., et al. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet. 349:1997;462-466.
23. Ridker PM, Rifai N, Pfeffer MA et al. for the Cholesterol And Recurrent Events (CARE) Investigators. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Circulation 1998;98:839-44.
24. Katus H.A., Remppis A., Neumann F.J., et al. Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation. 83:1991;902-912.
25. Hamm CW, Heeschen C, Goldmann BU et al. for the CAPTURE Study investigators. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels: c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators. New Engl J Med 1999;340:1623-9.
26. Antman E.M., Tanasijevic M.J., Thompson B., et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. New Engl J Med. 335:1996;1342-1349.
27. Hamm C.W., Goldmann B.U., Heeschen C., et al. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. New Engl J Med. 337:1997;1648-1653.
28. Hamm C.W., Ravkilde J., Gerhardt W., et al. The prognostic value of serum troponin T in unstable angina. New Engl J Med. 327:1992;146-150.
29. Lindahl B, Venge P, Wallentin L, for the FRISC study group. Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. J Am Coll Cardiol 1997;29:43-8.
30. Luescher M.S., Thygesen K., Ravkilde J., Heickendorff L. Applicability of cardiac troponin T and I for early risk stratification in unstable coronary disease. Circulation. 96:1997;2578-2585.
31. Ohman E.M., Armstrong P.W., Christenson R.H., et al. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. New Engl J Med. 335:1996;1333-1341.
32. Pettijohn T.L., Doyle T., Spiekerman A.M., et al. Usefulness of positive troponin T and negative creatine kinase levels in identifying high-risk patients with unstable angina pectoris. Am J Cardiol. 80:1997;510-511.
33. Ravkilde J., Nissen H., Horder M., Thygesen K. Independent prognostic value of plasma creatine kinase isoenzyme MB mass, cardiac troponin T and myosin light chain levels in suspected acute myocardial infarction. J Am Coll Cardiol. 25:1995;574-581.
34. Stubbs P., Collinson P., Path M.R.C., et al. Prognostic significance of admission troponin T concentrations in patients with myocardial infarction. Circulation. 94:1996;1291-1297.
35. Wu A., Abbas S.A., Green S., et al. Prognostic value of cardiac troponin T in unstable angina pectoris. Am J Cardiol. 76:1995;970-972.
36. Benamer H., Steg P.G., Benessiano J., et al. Elevated cardiac troponin I predicts a high-risk angiographic anatomy of the culprit lesion in unstable angina. Am Heart J. 137:1999;815-820.
37. Heeschen C, van den Brand MJ, Hamm CW, Simoons ML for the CAPTURE investigators. Angiographic findings in patients with refractory unstable angina according to troponin T status. Circulation 1999;100:1509-14.
38. Libby P., Hansson G.K. Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab Invest. 64:1991;5-15.
39. Neri Serneri G.G., Abbate R., Gori A.M., et al. A transient intermittent lymphocyte activation is responsible for the instability of angina. Circulation. 86:1992;790-797.
40. Katus H.A., Looser S., Hallermayer K., et al. Development and in vitro characterization of a new immunoassay of cardiac troponin T. Clin Chem. 38:1992;386-393.
41. Muller-Bardorff M., Hallermayer K., Schroeder A., et al. Improved T ELISA specific for cardiac troponin T isoform: assay development and analytical and clinical validation. J Clin Chem. 43:1997;458-466.
42. Gerhardt W., Katus H., Ravkilde J., et al. S-troponin T in suspected ischemic myocardial injury compared with mass and catalytic concentrations of S-creatine kinase isoenzyme MB. Clin Chem. 37:1991;1405-1411.
43. Brown C.S., Bertolet B.D. Cardiac troponin. See ya later CK (editorial; comment). Chest. 111:1997;2-4.
44. Hamm C.W., Goldman C.U., Heeschen C., et al. Emergency room triage of patients with acute chest pain by means by rapid testing for cardiac troponin T or troponin I. New Engl J Med. 337:1997;1648-1653.
45. Hlatky M.A. Evaluation of chest pain in the emergency department (editorial). New Engl J Med. 337:1997;1687-1689.
46. Peacock I.V.W.F., Emerman C.L., McErlean E.S., et al. Prediction of short and long term outcomes by troponin T levels in low-risk patients evaluated for acute coronary syndromes. Ann Emerg Med. 35:2000;213-220.
47. Ohman E.M., Armstrong P.W., Chrisyenson R.H., et al. Cardiac troponin T for risk stratification in acute myocardial infarction. New Engl J Med. 335:1996;1333-1341.
48. Lindahl B, Venge P, Wallentin L for the FRISC Study Group. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. Circulation 1996;93:1651-7.
49. Mullner M., Hirschl M.M., Herkner H., et al. Creatine kinase-MB fraction and cardiac troponin T to diagnose acute myocardial infarction after cardiopulmonary resuscitation. J Am Coll Cardiol. 28:1996;1220-1225.
50. Gokhan C.V., Gok H., Kaptanoglu B. The prognostic value of serum troponin T in unstable angina. Int J Cardiol. 53:1996;237-244.
51. Fitzgerald R.L., Frankel W.L., Herold D.A. Comparison of troponin T with other cardiac markers in a VA hospital. Am J Clin Pathol. 106:1996;396-401.
52. Selker H.P., Zalenski R.J., Antman E.M., et al. An evaluation of technologies for identifying acute cardiac ischemia in the emergency department: a report from a National Heart Attack Alert Program Working Group. Ann Emerg Med. 29:1997;13-87.
53. Maseri A., Chierchia S., L'Abbate A. Pathogenetic mechanisms underlying the clinical events associated with atherosclerotic heart disease. Circulation. 62:(suppl. V):1980;V3-V13.